Pharmaceuticals occupiers in Montreal typically cluster in Mile-Ex & Marconi, plan ~220 sqft per seat at high-end fit-out ($145–215/sqft), and pay around 38 CAD/sqft ($28 USD) on Class A.
Pharmaceuticals occupiers in Montreal typically cluster in Mile-Ex & Marconi, plan ~220 sqft per seat at high-end fit-out">fit-out ($145–215/sqft), and pay around 38 CAD/sqft ($28 USD) on Class A.
Pharmaceuticals occupiers in Montreal typically anchor in Mile-Ex & Marconi. AI research, tech, creative agencies, video games.
Class A rent in Montreal runs 38 CAD/sqft ($28 USD) on a 10-year lease with 12 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $145–215/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Montreal typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deepest French-English bilingual professional talent in North America. Structural AI research cluster (Yoshua Bengio at MILA, Element AI alumni). Strong aerospace, video games, and creative industries talent.
Headline corporate tax: 26.5%. Net leases (tenant pays opex separately). 10-year terms standard. Free rent of 10-14 months and TI of C$60-$100/sqft typical on a 10-year Class A deal.
| city | Montreal |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | Mile-Ex & Marconi |
| preferredFitoutSpec | High-end |
| fitoutBand | $145–215/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 38 CAD/sqft/yr |
| classARentUsd | $28/sqft/yr |
| vacancyPct | 18.6% |
| typicalLeaseYears | 10 |
| typicalRentFreeMonths | 12 |
| talentIndex | 86 |
| corporateTaxPct | 26.5% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.